Results

Total Results: 1,269 records

Showing results for "author year description".

1221. S44 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/s44.pdf
      October 01, 2007 - I heard they had decided on the 10 biggest hospitals getting funded 1 year, and the next year the next … 10, and the next year the next 10. … The scientific panel recommended a 1-year delay. … Our focus groups with clinicians revealed some discomfort with a delay of 1 year. … PharmaCare found the simplicity of the description very helpful.

1222. women-hiv-protocol-160301 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
      March 01, 2016 - limit results to studies published after 01/01/2005, published in English, and having at least one author … months to be fully indexed, we will search using only free text terms for studies published in the last year

1223. Renal-Function Research-Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
      June 13, 2013 - Smoking status j. 10-year coronary heart disease (CHD) risk k. History of CAD 3. … Smoking status j. 10-year coronary heart disease (CHD) risk k. … Smoking status j. 10-year CHD risk k. History of CAD 4. … These studies adhered to the commonly held concepts of high quality, including the following: a clear description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1224. Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA) (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
      January 01, 2010 - In addition, we have provided an example of an expanded and limited screening strategy in the description … Beyond that, the Robiscek paper had moderately more rigorous statistical methodology and a better description … invasive MRSA infections in the population and 25% reduction in MRSA bacteremia in hospitals over a 5-year … Each article included in their analysis is discussed in detail, with a description of the quality of

1225. Template for Reports Developed (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
      November 01, 2012 - The Cover Sheet, typically seven to eight pages long, includes a description of the nomination, background … Cover Sheet The Cover Sheet includes a description of the nomination, comprising a summary of the … 13 Summary of nomination’s fit with appropriateness and importance criteria Disease burden Description … and a link to sign up for notification when Key Questions are posted for public comment Topic description

1226. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism-adolescents_research-protocol.pdf
      March 29, 2011 - participant characteristics (age, diagnosis, symptom severity, etc.), intervention characteristics (description … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1227. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/deliberative-methods/research-2013-1
      January 01, 2019 - Deliberative Methods Demonstration Description Between August and November 2012, we conducted a five-arm

1228. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
      June 01, 2010 - annually, and is projected to reduce initial neonatal medical costs by more than $505 million each year … table will vary according to Key Question, but the Tables will contain some common elements (e.g., author … , publication year, study location, time period, population description, sample size, and study type … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1229. Disparities-Quality-Improvement Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
      August 01, 2012 - Summary of effects on disparities in health outcomes associated with race or ethnicity Author, Year … Summary of effects on disparities in health outcomes associated with insurance status Author, Year, … Summary of effects on disparities in health outcomes associated with socioeconomic status Author, Year … Summary of effects on disparities in health outcomes associated with sex Author, Year, Study Design … Duration of studies was generally 1 year.

1230. FRN 40 - Screening for Methicillin-Resistant Staphylococcus aureus (MRSA): Future Research Needs (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
      June 01, 2013 - The findings and conclusions in this document are those of the author(s), who are responsible for its … is most valid and important to report and generalizable across all health care settings with clear description … Design Considerations Cohort Study Nested Case-Control Study Case-Control Study Cross-Sectional Study Description … Meticillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. … Hospital-wide methicillin-resistant Staphylococcus aureus control program: a 5-year follow-up.

1231. Liver-Cancer-Therapy Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
      May 01, 2013 - is the fifth most common cancer and the third leading cause of cancer death worldwide.1 Overall 5-year … In the other RCT, 3-year cancer- free survival was 43%, 21%, and 23% in the RFA, PEI, and PAI groups … and 42.5% at 2 years for TACE, and 69.8% at 1 year and 58.8% at 2 years for TEA; p = 0.0588). … The clinical heterogeneity was most evident in the description of patient and tumor characteristics … Full description of the patient population is important, as those with, for example, higher ECOG score

1232. CER 45 Self-Measured Blood Pressure Monitoring Comparative Effectiveness Surveillance Final 4.7.16 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
      April 11, 2016 - and"self"management"programme"(DESMOND)"for"people"with"newly"diagnosed"type"2" diabetes"mellitus:"three"year"follow'up"of"a"cluster"randomised"controlled"trial"in"primary … Novel" description"of"the"24'hour"circadian"rhythms"of"brachial"versus"central"aortic"blood" pressure"and"the"impact"of"blood"pressure"treatment"in"a"randomized"controlled"clinical

1233. Survey of Medicare Part D Plans’ Medication Therapy Management Programs (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
      January 01, 2007 - ..............................................................................................13 Author … To the best of our knowledge, this analysis is the first description of MTM programs developed as part … A four-year analysis of an ambulatory care model. Arch Intern Med 1984;144(6):1159-62. 14. … Improving adherence and persistence: a review and assessment of interventions and description of steps … How often does the plan provide for MTM services (e.g., annually, twice a year, quarterly)? 8.

1234. Ced-Appendix-3 (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ced-appendix-3.xlsx
      June 24, 2022 - TableOfContent Table of content Abstraction of criteria from existing sources Sheet number [Click to go to specific sheet] Pearson et. al 2018, white paper 1 Duke Margolis 2017, white paper 2 International Society for Pharmacoepidemiology (ISPE) position paper 3 Berger et al. 2017 (ISPOR-ISPE) 4 Wang e…

1235. Comparative Effectiveness of Preventive Pharmacological Treatments for Migraine | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/migraine-prevention/research-protocol
      December 01, 2019 - Each year, lost work time and diminished productivity from migraines costs American employers $225.8 … Cephalalgia. 2007 May;27(5):469; author reply -70. PMID 17448186. … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

1236. Comparative Effectiveness of Strategies to De-escalate Aggressive Behavior in Psychiatric Patients in Acute Care Settings (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
      October 01, 2016 - Furthermore, the inexact description of many interventions made it difficult to attribute a change to … Effectiveness and efficiency of cognitive-behavioral group therapy for inpatients: 4-year follow-up study

1237. Pressure-Ulcer-Treatment Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
      May 01, 2013 - The data extracted into evidence tables included study design; year, setting, duration, and study inclusion

1238. Simulation-Based Comparison of Methods and Meta-Analysis of Proportions and Rates (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/metanalysis-proportion-rate-comparison_research.pdf
      November 01, 2013 - Description of performance metrics for the estimated summary proportions and rates ....4 Table 2. … Description of performance metrics for the estimated summary proportions and rates Metric Formula Description … Similarly, 𝜆𝑗is the true rate and its estimate is 𝜆�𝚤𝚥, in simulation 𝑖. 4 Description … Simulation parameters for rates # Parameter Description or Values 1 Distribution of summary rates … Pseudo-algorithm for generating random data Step Description Simulation Table Row # Comment For

1239. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
      June 01, 2017 - We included an overlap of more than 1 year with the search done for the 2012 VTE report. … These included population characteristics, including description of patients’ surgery, descriptions … Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance

1240. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
      June 01, 2017 - We included an overlap of more than 1 year with the search done for the 2012 VTE report. … These included population characteristics, including description of patients’ surgery, descriptions … Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance